Aims: To measure the content of immunoreactive human pancreatic secretory trypsin inhibitor (irPSTI) in colonic carcinoma and adjacent normal colonic mucosa.
Pancreatic secretory trypsin inhibitor (PSTI) was first isolated from pancreatic tissue in 1948 by Kazal.' PSTI is thought to protect the pancreatic gland from damage by preactivated trypsin. The serum concentration of immunoreactive PSTI (irPSTI) is increased in severe diseases such as carcinoma of pancreatic gland, breast, thyroid, stomach, oesophagus,2 and gall bladder.' irPSTI has also been shown in and isolated from different parts of the normal gastrointestinal mucosa.4 "' irPSTI has been found in the foveolar cells in the gastric mucosa. In duodenal and small intestinal mucosa irPSTI found in Paneth5 7 and goblet cells.58 Normal gall bladder mucosa did not contain irPSTI while well differentiated carcinoma and tissue resembling adenoma did."
In colonic mucosa ir PSTI has been found in the goblet cells in the basal parts of the crypts. 6 In colonic adenomas, however, irPSTI was also found in the upper parts of the polyps following the reverse mode of regeneration. ' Microtitre plates were coated with 50 pl of rPSTI, 10 ,ug/ml. Hybridomas producing antibodies specific for PSTI were selected for cloning. The subclass type of the monoclonal antibodies produced was determined by the double immunodiffusion test.'6 Cells harvested from cultures of hybridomas producing monoclonal antibodies against PSTI were injected intraperitoneally into BALB/c mice treated with Pristane (Aldrich, Beerse, Belgium) for the production of ascites fluid. The ascites fluid was purified by affinity chromatography on a protein A sepharose CI-4B column equilibrated with 1-5 M glycineNaOH, 3 M NaCI, at pH 8 9. The column was washed with this buffer after application of the ascites fluid and the IgG was eluted stepwise with 0-1 M citric acid-NaOH at pH 6-0, pH 50, pH 4-0 and pH 30. IgGl was eluted at pH 6-0. This IgGI fraction was loaded on a CNBr-activated sepharose CI-4B column covalently attached with 70 mg rPSTI. Non-specific binding protein was eliminated by rinsing the column with the TRIS-HCI buffer and specific elution of the PSTI antibodies was accomplished using reversed flow elution with 0-1 M glycine/HCl, 3M NaCI, at pH 3 0. RABBIT colonic carcinomas). Clinical examination of the patients preoperatively did not reveal any other serious disease. From each resected colonic specimen one piece was taken from the carcinoma and one piece from the normal mucosa. The specimens were frozen and stored at -20°C for later analysis. The specimens were thawed and homogenised in four parts 0 05 mM acetic acid with aprotinin (Trasylol) 500 KIU/ml. The homogenates were freezethawed five times. The homogenates were centrifuged 15000 x g for 10 minutes. The supernatants were collected. The precipitates were suspended in two parts acetic acid twice and centrifuged after each suspension. The three supernatant fluids were pooled and stored at -20°C until analysed with the above described ELISA and protein concentration by a modification of Lowry's method. '7 Histological evaluation was done according to WHO tumour classification and grading. '8 The Wilcoxon matched-pairs signed ranks test was used for statistical analysis.
Results
The immunoprecipitation of PSTI by monoclonal antibodies showed a dose dependent binding of PSTI to the antibody. In the ELISA the intra-assay variation was 7% and the interassay variation was 13%. The lower limit of detection was 1 ,ug/l. The same recovery was obtained for PSTI in the tissue samples after dilution as after dilution of pure human PSTI (parallel dilution curves). 
